Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

v3.5.0.2
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS        
Revenue $ 2,416 $ 4,948 $ 5,662 $ 10,459
Operating expenses        
Research and development (15,610) (8,853) (46,942) (23,838)
General and administrative (5,424) (4,403) (16,863) (11,643)
Total operating expenses (including purchases from related parties, net of reimbursements of $523, $1,352, $1,852 and $2,606) (21,034) (13,256) (63,805) (35,481)
Operating loss (18,618) (8,308) (58,143) (25,022)
Interest income 289 235 839 533
Other (expense) income, net (61) 1,851 1,595 1,952
Loss before income taxes (18,390) (6,222) (55,709) (22,537)
Income taxes (104) (20) (456) (218)
Net loss (18,494) (6,242) (56,165) (22,755)
Deemed dividend on convertible preferred shares       (8,663)
Net loss attributable to ordinary shareholders $ (18,494) $ (6,242) $ (56,165) $ (31,418)
Net loss per ordinary share basic and diluted (Note 4) (in dollars per share) $ (0.04) $ (0.01) $ (0.13) $ (0.10)
Weighted average shares outstanding, basic and diluted (in shares) 424,711,900 424,711,900 424,711,900 307,943,490